Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Batoclimab, an anti-FcRn antibody developed by HanAll Biopharma, has received Orphan Drug Designation from Japan's MHLW for active Thyroid Eye Disease, a rare condition affecting approximately 35,000 Japanese patients.
HanAll Biopharma reported a revenue increase of 11.7% to 36.8 billion KRW in Q3 2024, with operating profit reaching 430 million KRW.